The widely expected announcement marks the latest and most significant implementation of provisions from the Inflation Reduction Act, which was passed last summer.
In the absence of broader federal privacy regulation, the Federal Trade Commission has cracked down on healthcare companies using data for marketing purposes.
Health policy issues remain unaddressed as Congress nears summer recess
While a divided Capitol Hill may not give way to any major legislation this year, health policy issues like drug pricing and the fentanyl crisis are likely to be addressed.
Bernie Sanders puts NIH nom in crosshairs over drug pricing fight
The company is suing the federal government over drug pricing regulation included in the Inflation Reduction Act, arguing that the provision is “tantamount to extortion.”
With latest Medicaid proposal, White House continues drug pricing push
A Senate HELP Committee hearing left much to be desired when it comes to clarity on high drug prices. But some experts believe the needle is still shifting on change.
‘Isolated and invisible’: Surgeon General Vivek Murthy singles out loneliness as public health threat
In an advisory announced this week, Vivek Murthy outlined the ways social connection has been on the decline in the U.S. — and what it might mean for health outcomes.
Bipartisan support grows for PBM reform, despite pushback from industry groups